ID   KPSH2_HUMAN             Reviewed;         385 AA.
AC   Q96QS6; A0AV22;
DT   06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   12-OCT-2022, entry version 158.
DE   RecName: Full=Serine/threonine-protein kinase H2;
DE            EC=2.7.11.1;
DE   AltName: Full=Protein serine kinase H2;
DE            Short=PSK-H2;
GN   Name=PSKH2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Scharm B.;
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASP-72; LYS-79; GLN-114; ILE-116; ARG-132;
RP   GLN-148; SER-176; ARG-211; ILE-212; ALA-225; ARG-266 AND VAL-336.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- INTERACTION:
CC       Q96QS6; Q16543: CDC37; NbExp=3; IntAct=EBI-6424813, EBI-295634;
CC       Q96QS6; P07900: HSP90AA1; NbExp=2; IntAct=EBI-6424813, EBI-296047;
CC       Q96QS6; P08238: HSP90AB1; NbExp=3; IntAct=EBI-6424813, EBI-352572;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- CAUTION: Asn-183 is present instead of the conserved Asp which is
CC       expected to be an active site residue. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY037806; AAK59985.1; -; mRNA.
DR   EMBL; BC126180; AAI26181.1; -; mRNA.
DR   EMBL; BC126182; AAI26183.1; -; mRNA.
DR   CCDS; CCDS6240.1; -.
DR   RefSeq; NP_149117.1; NM_033126.2.
DR   AlphaFoldDB; Q96QS6; -.
DR   SMR; Q96QS6; -.
DR   BioGRID; 124556; 12.
DR   IntAct; Q96QS6; 65.
DR   STRING; 9606.ENSP00000276616; -.
DR   iPTMnet; Q96QS6; -.
DR   PhosphoSitePlus; Q96QS6; -.
DR   BioMuta; PSKH2; -.
DR   DMDM; 74762688; -.
DR   MassIVE; Q96QS6; -.
DR   PaxDb; Q96QS6; -.
DR   PeptideAtlas; Q96QS6; -.
DR   PRIDE; Q96QS6; -.
DR   Antibodypedia; 12608; 124 antibodies from 26 providers.
DR   DNASU; 85481; -.
DR   Ensembl; ENST00000276616.3; ENSP00000276616.2; ENSG00000147613.8.
DR   GeneID; 85481; -.
DR   KEGG; hsa:85481; -.
DR   MANE-Select; ENST00000276616.3; ENSP00000276616.2; NM_033126.3; NP_149117.1.
DR   UCSC; uc011lfy.3; human.
DR   CTD; 85481; -.
DR   DisGeNET; 85481; -.
DR   GeneCards; PSKH2; -.
DR   HGNC; HGNC:18997; PSKH2.
DR   HPA; ENSG00000147613; Tissue enriched (retina).
DR   neXtProt; NX_Q96QS6; -.
DR   PharmGKB; PA134961168; -.
DR   VEuPathDB; HostDB:ENSG00000147613; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   GeneTree; ENSGT00940000162917; -.
DR   HOGENOM; CLU_000288_63_0_1; -.
DR   InParanoid; Q96QS6; -.
DR   OMA; DHPWVIT; -.
DR   OrthoDB; 330091at2759; -.
DR   PhylomeDB; Q96QS6; -.
DR   TreeFam; TF314166; -.
DR   PathwayCommons; Q96QS6; -.
DR   SignaLink; Q96QS6; -.
DR   BioGRID-ORCS; 85481; 10 hits in 1093 CRISPR screens.
DR   ChiTaRS; PSKH2; human.
DR   GenomeRNAi; 85481; -.
DR   Pharos; Q96QS6; Tdark.
DR   PRO; PR:Q96QS6; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q96QS6; protein.
DR   Bgee; ENSG00000147613; Expressed in adult mammalian kidney and 11 other tissues.
DR   Genevisible; Q96QS6; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Kinase; Nucleotide-binding; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..385
FT                   /note="Serine/threonine-protein kinase H2"
FT                   /id="PRO_0000086171"
FT   DOMAIN          63..320
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          342..367
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        342..359
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         69..77
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         92
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   VARIANT         72
FT                   /note="G -> D (in dbSNP:rs56407605)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040615"
FT   VARIANT         79
FT                   /note="R -> K (in dbSNP:rs35315725)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040616"
FT   VARIANT         114
FT                   /note="R -> Q (in dbSNP:rs35915498)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040617"
FT   VARIANT         116
FT                   /note="S -> I (in a lung adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040618"
FT   VARIANT         132
FT                   /note="Q -> R (in dbSNP:rs16879427)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040619"
FT   VARIANT         148
FT                   /note="R -> Q (in dbSNP:rs56356246)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040620"
FT   VARIANT         176
FT                   /note="A -> S (in dbSNP:rs6998760)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040621"
FT   VARIANT         211
FT                   /note="G -> R (in dbSNP:rs36074412)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040622"
FT   VARIANT         212
FT                   /note="K -> I (in a lung adenocarcinoma sample; somatic
FT                   mutation; dbSNP:rs778066815)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040623"
FT   VARIANT         225
FT                   /note="T -> A (in dbSNP:rs34457516)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040624"
FT   VARIANT         266
FT                   /note="S -> R (in dbSNP:rs34037815)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040625"
FT   VARIANT         336
FT                   /note="I -> V (in dbSNP:rs16876805)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040626"
SQ   SEQUENCE   385 AA;  43027 MW;  6472D63BC7688334 CRC64;
     MGCGASRKVV PGPPALAWAK HEGQNQAGVG GAGPGPEAAA QAAQRIQVAR FRAKFDPRVL
     ARYDIKALIG TGSFSRVVRV EQKTTKKPFA IKVMETRERE GREACVSELS VLRRVSHRYI
     VQLMEIFETE DQVYMVMELA TGGELFDRLI AQGSFTERDA VRILQMVADG IRYLHALQIT
     HRNLKPENLL YYHPGEESKI LITDFGLAYS GKKSGDWTMK TLCGTPEYIA PEVLLRKPYT
     SAVDMWALGV ITYALLSGFL PFDDESQTRL YRKILKGKYN YTGEPWPSIS HLAKDFIDKL
     LILEAGHRMS AGQALDHPWV ITMAAGSSMK NLQRAISRNL MQRASPHSQS PGSAQSSKSH
     YSHKSRHMWS KRNLRIVESP LSALL
//
